Digitek (Digoxin Tablets) Recalled by Pharmaceutical Company
Digitek, a generic version of Digoxin, is used to treat heart failure and abnormal heart rhythms, helping the heart contract and beat more efficiently. In April 2008, Actavis Totowa LLC, a United States manufacturing division of the pharmaceutical company Actavis Group, initiated a Class 1 nationwide recall of the prescription. The Digitek recall was issued because of the possibility that pills with double the approved thickness and twice the approved level of active ingredient were marketed to the public. Distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label, the tablets may cause harmful side effects to some patients.
Digitek Side Effects
In patients that have renal (kidney) failure, the existence of the double strength tablets poses a risk of digitalis toxicity. Digitalis (Digoxin) toxicity may cause:
- Low blood pressure
- Cardiac instability
- Bradycardia (a slower than normal heart rate)
Call 1-888-BURNETTI For Digitek Information
Individuals who are able to demonstrate actual harm after taking Digitek may be eligible to receive compensation. For more information, call 1-888-BURNETTI.
Calls Answered 24 Hours Day / 7 Days A Week
Se Habla Español